Inhibikase Therapeutics, Inc.
IKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750149
No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Inhibikase Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +16 vs. Q4 2024
- Shares held
- 51.5M
- +1.40M (+2.8%) vs. Q4 2024
- Total value
- $112.7M
- −$50.0M (−30.7%) vs. Q4 2024
- New holders
- 19
- 12 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $239.2M |
| Q1 2026 | 104 | $193.4M |
| Q4 2025 | 74 | $218.2M |
| Q3 2025 | 54 | $89.0M |
| Q2 2025 | 48 | $106.3M |
| Q1 2025 | 47 | $112.7M |
| Q4 2024 | 31 | $162.7M |
| Q3 2024 | 11 | $1.12M |
| Q2 2024 | 12 | $1.02M |
| Q1 2024 | 12 | $443.8K |
| Q4 2023 | 11 | $298.9K |
| Q3 2023 | 13 | $597.6K |
| Q2 2023 | 14 | $2.69M |
| Q1 2023 | 17 | $2.91M |
| Q4 2022 | 19 | $719.4K |
| Q3 2022 | 24 | $2.78M |
| Q2 2022 | 22 | $2.49M |
| Q1 2022 | 24 | $6.33M |
| Q4 2021 | 26 | $6.85M |
| Q3 2021 | 21 | $7.78M |
| Q2 2021 | 14 | $10.6M |
| Q1 2021 | 9 | $975.0K |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 167 | $366 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 1,980 | $4.34K | 0.00% | +1,980 | New |
| Cubist Systematic Strategies, LLC | 9,043 | $19.8K | 0.00% | +9,043 | New |
| Brevan Howard Capital Management LP | 10,384 | $22.7K | 0.00% | +10,384 | New |
| Capstone Investment Advisors, LLC | 11,067 | $24.2K | 0.00% | +11,067 | New |
| Prelude Capital Management, LLC | 11,098 | $24.3K | 0.00% | +11,098 | New |
| Quantessence Capital LLC | 13,005 | $28.5K | 0.01% | +13,005 | New |
| Stifel Financial Corp | 13,129 | $28.8K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 13,712 | $30.0K | 0.01% | +13,712 | New |
| Jefferies Financial Group Inc. | 14,800 | $32.4K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 14,976 | $32.8K | 0.01% | +14,976 | New |
| Caxton Corp | 16,393 | $35.9K | 0.71% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 16,876 | $37.0K | 0.00% | +16,876 | New |
| Morgan Stanley | 21,646 | $47.4K | 0.00% | +14,350+196.7% | Added |
| Citigroup Inc | 25,765 | $56.4K | 0.00% | −51,335−66.6% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 26,775 | $58.6K | 0.00% | +26,775 | New |
| Diametric Capital, LP | 28,366 | $62.1K | 0.07% | +28,366 | New |
| LMR Partners LLP | 31,092 | $68.1K | 0.00% | +31,092 | New |
| ExodusPoint Capital Management, LP | 32,538 | $71.0K | 0.00% | +32,538 | New |
| Qube Research & Technologies Ltd | 35,625 | $78.0K | 0.00% | +35,625 | New |
| State Street Corp | 41,884 | $91.7K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 45,026 | $98.6K | 0.00% | +40,517+898.6% | Added |
| UBS Group AG | 45,266 | $99.1K | 0.00% | +17,740+64.4% | Added |
| Jain Global LLC | 54,845 | $120.1K | 0.00% | +54,845 | New |
| Omers Administration Corp | 56,000 | $122.6K | 0.00% | +1,400+2.6% | Added |
| Northern Trust Corp | 64,011 | $140.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 65,906 | $144.0K | 0.00% | +19,490+42.0% | Added |
| Balyasny Asset Management LLC | 81,161 | $177.7K | 0.00% | +81,161 | New |
| Barclays PLC | 84,000 | $184.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 116,249 | $254.6K | 0.00% | +116,249 | New |
| Marshall Wace, LLP | 155,270 | $340.0K | 0.00% | +155,270 | New |
| Blair William & Co | 155,953 | $341.5K | 0.00% | +21,000+15.6% | Added |
| Goldman Sachs Group Inc | 166,025 | $363.6K | 0.00% | +122,073+277.7% | Added |
| Geode Capital Management, LLC | 324,760 | $711.3K | 0.00% | +1,882+0.6% | Added |
| BlackRock, Inc. | 423,979 | $928.5K | 0.00% | +88,519+26.4% | Added |
| Susquehanna International Group, LLP | 504,625 | $1.11M | 0.00% | +504,625 | New |
| Millennium Management LLC | 913,502 | $2.00M | 0.00% | +771,293+542.4% | Added |
| Stonepine Capital Management, LLC | 914,973 | $2.00M | 2.33% | −217,415−19.2% | Reduced |
| Blackstone Group Inc. | 2,070,684 | $4.53M | 0.02% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 2,190,000 | $4.80M | 0.40% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,848,663 | $6.24M | 0.00% | +10,018+0.4% | Added |
| ADAR1 Capital Management, LLC | 5,122,105 | $11.2M | 2.16% | +19,100+0.4% | Added |
| Commodore Capital LP | 5,344,432 | $11.7M | 0.86% | −580,568−9.8% | Reduced |
| Perceptive Advisors LLC | 5,925,000 | $13.0M | 0.46% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 6,125,000 | $13.4M | 2.08% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 6,325,000 | $13.9M | 1.09% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 10,950,000 | $24.0M | 5.86% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,411−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −14,842−100.0% | Sold out |
| Synergy Financial Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |